ResearchApr 14, 20260 views

Tropical psychotria plants are a rich source for peptide inhibitors of human prolyl oligopeptidase.

Tropical psychotria plants just made peptide research a lot more interesting. A team from Vienna and Queensland screened eleven Psychotria species and found a goldmine of cyclic cysteine-rich peptides that target human prolyl oligopeptidase (POP). Why care about POP? It’s a hot enzyme in neurobiology and peptide inhibitor circles, often linked to cognitive processes and research into neurodegeneration.

P

Nat Prod Bioprospect

by Hellinger R, Schwarz P, Dieringer J et al.

Tropical psychotria plants are a rich source for peptide inhibitors of human prolyl oligopeptidase. Hellinger R(1), Schwarz P(1), Dieringer J(1), Ebermann C(1), Jadhav KB(2), Muttenthaler M(2)(3), Gruber CW(4). Author information: (1)Center for Physiology and Pharmacology, Medical University of Vienna, 1090, Vienna, Austria. (2)Institute of Biological Chemistry, Faculty of Chemistry, University of Vienna, 1090, Vienna, Austria. (3)Institute for Molecular Bioscience, The University of Queensland, Brisbane, 4072, Australia. (4)Center for Physiology and Pharmacology, Medical University of Vienna, 1090, Vienna, Austria. christian.w.gruber@meduniwien.ac.at. Peptides from natural sources have often served as valuable leads in drug discovery. Plant-derived protease inhibitors are a notable class, yet their distribution, diversity, and targets remain underexplored. Here, eleven tropical Psychotria species were screened for cyclic cysteine-rich peptides, with extracts showing concentration-dependent inhibition of human prolyl oligopeptidase (POP). Peptidomics combining mass spectrometry and transcriptome mining revealed multiple inhibitory peptides. From Psychotria solitudinum, which contained 37 peptides, a novel peptide (psysol 3) was purified and sequenced. Its synthetic analogue inhibited POP with an IC50 of ~ 1.3 µM. Sequence analysis and synthetic probes identified loop 3 as the inhibitory motif. Psysol 3 is a new probe for POP pharmacology and future structure-activity studies. © 2026. The Author(s). Conflict of interest statement: Declarations. Ethics approval and consent to participate: The research adhered to the Declaration of Helsinki and institutional protocols, receiving approval from the Ethical Board of the Medical University of Vienna (EK1548/2020). Prior to blood donation, volunteers gave written informed consent. No gender or sex analysis was conducted, as it is expected that human active serum will demonstrate uniform activity in both sexes. A total of six volunteers participated in the blood sample collection. Competing interests: The authors report there are no competing interests to declare.

The researchers didn’t just skim the surface. They used peptidomics—mass spectrometry plus transcriptome mining—to map out the peptides in these plants. The standout: Psychotria solitudinum, boasting 37 unique peptides. Among those, they purified and sequenced a novel compound, psysol 3. When they synthesized it and put it to the test, psysol 3 clocked an IC50 of about 1.3 μM against POP. That’s real potency for a plant-derived research peptide.

Key takeaway: Loop 3 in the psysol 3 sequence is where the inhibition magic happens. Synthetic probes confirmed this, pointing researchers toward new ways to tweak and study POP inhibition.

Why does this matter for the research community?

Natural peptides are still a top-tier source for new research compounds.

Plant-derived inhibitors are underexplored, so expect more surprises.

Tools like mass spectrometry and transcriptomics are making peptide discovery way faster and more precise.

For anyone building peptide libraries or looking for new scaffolds, this study opens up fresh territory. Psychotria peptides now join the list of natural compounds worth a deeper look.

Want more on this kind of discovery? Check out the peptide research index for the latest updates and foundational info.

Plant peptides aren’t done surprising us—expect more breakthroughs as researchers keep digging.

For Research Use Only

All content published on Pushing Peptides is intended for educational and informational purposes only. The information provided is not intended as medical advice, diagnosis, or treatment. Peptides discussed in this article are research compounds and are not approved for human therapeutic use by the FDA or any other regulatory agency. All studies referenced involve animal models or in vitro research unless otherwise stated. Consult a qualified healthcare professional before making any decisions related to your health. Pushing Peptides does not sell peptides — we are a vendor directory and educational resource.